Speaker Profile
M.D.,Ph.D., Vice President, Real World Evidence, Guardant Health
Biography
Dr. Amar Das has three decades of experience in advancing clinical researchthrough data science and AI. At Guardant Health, he leads a team thatgenerates real world evidence for blood-based testing in precision oncologyand cancer screening. Prior to Guardant Health, Dr. Das was on the facultyat Stanford and Dartmouth. As Director of Biomedical Informatics atDartmouth, he co-founded the Department of Biomedical Data Science, thefirst department focused on this discipline. Following his career inacademia, he served as Director of Healthcare Effectiveness Research at IBMand Director of Real World Data Analytics and Innovation at MerckMSD. Dr.Das has received multiple professional and research awards, and is a Fellowof the American College of Medical Informatics. Dr. Das received his MD andPhD in Biomedical Informatics from Stanford and completed his residency andpostdoctoral fellowship in Clinical Epidemiology at ColumbiaNew YorkPresbyterian.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Alex Morgan, Khosla Ventures and Gad Getz, Broad Institute
PMWC Award Ceremony
• Steve Wozniak, Apple
• Greg Brockman, OpenAI
Fireside Chat
• Vinod Khosla, Khosla Ventures
• Greg Brockman, OpenAI
Target Discovery: Beyond Genomics – Revealing Hidden Layers of Biology with AI
• Keynote: Stephen Quake, CZ Biohub
• Chair: Cindy Lawley, Olink
• Aritro Nath, City of Hope
• Massa Shoura, Phinomics
• Omar Serang, DNAnexus
Accelerating Immunotherapy Discovery Through Multimodal AI
• Ron Alfa, Noetik
A Data-Integrated Approach to Target and Biomarker Discovery
• Liat Dassa, Cytoreason
Harmonizing Data to Accelerate Drug Discovery
• Vitalay Fomin, Numenos
Closing the Loop: Coupling AI with In Vivo Validation
• Gabriel Musso, Biosymetrics
Interpretable AI for Biomarker Discovery: Accelerating Drug Development
• Sanoj Punnen, University of Miami
• Shivanni Kummar, OHSU
• Mark Burkard, UI
Can AI Really Create the Next Blockbuster Drug?
• Chair: Amar Das, Guardant Health
• Ari Caroline, Weave Bio
• Dina Katabi, Emerald/MIT
• Andrei Georgescu, Vivodyne
• James Zou, Stanford
Gemini Digital Twins Accelerate Precision Medicine
• Collin Hill, Aitia
Scaling Rare Disease Discovery with AI
• Lisa Gurry, GeneDx
Enabling Targeted Precision Drug & Gene Delivery with Predictive AI
• Andre Watson, Ligandal
Is AI the New Drug or the New Therapeutic Modality
• Chair: Alex Morgan, Khosla Ventures
• Michael J. Kahana, Nia Therapeutics
• Marc Tessier-Lavigne, Xaira
